Home Cart 0 Sign in  
X

[ CAS No. 1603-41-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 1603-41-4
Chemical Structure| 1603-41-4
Chemical Structure| 1603-41-4
Structure of 1603-41-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1603-41-4 ]

Related Doc. of [ 1603-41-4 ]

Alternatived Products of [ 1603-41-4 ]

Product Details of [ 1603-41-4 ]

CAS No. :1603-41-4 MDL No. :MFCD00006328
Formula : C6H8N2 Boiling Point : -
Linear Structure Formula :- InChI Key :CMBSSVKZOPZBKW-UHFFFAOYSA-N
M.W : 108.14 Pubchem ID :15348
Synonyms :

Calculated chemistry of [ 1603-41-4 ]

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.17
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 33.61
TPSA : 38.91 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.24 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.28
Log Po/w (XLOGP3) : 1.02
Log Po/w (WLOGP) : 0.98
Log Po/w (MLOGP) : 0.54
Log Po/w (SILICOS-IT) : 1.14
Consensus Log Po/w : 0.99

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.71
Solubility : 2.12 mg/ml ; 0.0196 mol/l
Class : Very soluble
Log S (Ali) : -1.43
Solubility : 4.05 mg/ml ; 0.0374 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.99
Solubility : 1.11 mg/ml ; 0.0103 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.21

Safety of [ 1603-41-4 ]

Signal Word:Danger Class:6.1
Precautionary Statements:P261-P280-P305+P351+P338-P311 UN#:2811
Hazard Statements:H301+H311+H331-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 1603-41-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1603-41-4 ]
  • Downstream synthetic route of [ 1603-41-4 ]

[ 1603-41-4 ] Synthesis Path-Upstream   1~56

  • 1
  • [ 3510-66-5 ]
  • [ 1603-41-4 ]
YieldReaction ConditionsOperation in experiment
100% With [Cu2(2,7-bis(pyridin-2-yl)-l,8-naphthyridine)(OH)(CF3COO)3]; tetrabutylammomium bromide; ammonia; caesium carbonate In water at 110 - 120℃; for 16 h; Sealed tube General procedure: A mixture of substrate (0.25 mmol), complex 1 (2.5 × 10− 3 mmol), Cs2CO3 (1 mmol), Conc. NH3(aq) (0.5 mL) and TBAB (0.25 mmol) in water (0.5 mL) were loaded in a sealed reaction tube. The reaction temperature was increased to 110–140 °C and the reaction mixture was stirred for 8–24 h. After cooling to RT, the reaction mixture was poured into a saturated NaCl solution, extracted with ethyl acetate and dried over anhydrous MgSO4. After removal of solvents, the residue was re-crystallized or chromatographed on silica gel. All products were characterized by NMR spectroscopy and were consistent with the literature data.
Reference: [1] Catalysis Communications, 2013, vol. 32, p. 28 - 31
[2] Advanced Synthesis and Catalysis, 2009, vol. 351, # 11-12, p. 1722 - 1726
  • 2
  • [ 108-99-6 ]
  • [ 1603-41-4 ]
  • [ 1603-40-3 ]
YieldReaction ConditionsOperation in experiment
1928 g With ammonia; sodium; ethanolamine In toluene at 60 - 170℃; Autoclave; Inert atmosphere; Large scale 1) Add 9021g of toluene, 538g of sodium metal, 70g of ethanolamine and 1900g of 3-picoline to the autoclave. After tightening the autoclave, open the autoclave inlet and the addition port of the dropping tank, and open the dropping tank And the kettle body valve, the hose through the feeding port into the bottom of the tank, with nitrogen replacement air for 1min, closed the lid of the feeding port, warmed to 60 , dropping liquid ammonia, control the pressure in the autoclave 3MPa, the final Liquid ammonia added amount of 600g. Fully respond.2) The temperature was raised to 170 ° C, nitrogen was filled to a pressure of 5 MPa, and the reaction was sufficiently completed. When the pressure in the autoclave increased to 5.5 MPa,Pressure relief to 5MPa, repeat this operation until the pressure inside the reactor does not rise as the end of the reaction, down to room temperature.3) The ammoniated liquid was taken out and slowly added dropwise to water (9 kg). The mixture was stirred and hydrolyzed and extracted, and the mixture was allowed to stand still. After the aqueous phase was extracted again with 3 L of toluene, the oil phases were combined and the oil phase was quantified by gas chromatography.Among them, 1928g of 2-amino-5-methylpyridine and 144g of 2-amino-3-methylpyridine.
Reference: [1] Patent: US2456379, 1946, ,
[2] Patent: CN106496105, 2017, A, . Location in patent: Paragraph 0024; 0025; 0026; 0027; 0028; 0029; 0030-0035
  • 3
  • [ 1003-73-2 ]
  • [ 1603-41-4 ]
Reference: [1] Heterocycles, 1987, vol. 26, # 8, p. 2065 - 2068
[2] Bioorganic and medicinal chemistry letters, 2000, vol. 10, # 17, p. 1975 - 1978
[3] Chemical and Pharmaceutical Bulletin, 1980, vol. 28, # 2, p. 465 - 472
[4] Patent: US5332824, 1994, A,
[5] Patent: US5332824, 1994, A,
  • 4
  • [ 108-99-6 ]
  • [ 1603-41-4 ]
Reference: [1] Patent: CN105801472, 2016, A, . Location in patent: Paragraph 0007
[2] Patent: CN107266361, 2017, A,
  • 5
  • [ 18368-64-4 ]
  • [ 1603-41-4 ]
Reference: [1] Organic Letters, 2013, vol. 15, # 14, p. 3734 - 3737
  • 6
  • [ 100047-39-0 ]
  • [ 1603-41-4 ]
Reference: [1] Patent: CN107266361, 2017, A, . Location in patent: Paragraph 0025; 0030; 0036; 0038; 0040; 0042
  • 7
  • [ 7757-82-6 ]
  • [ 1603-41-4 ]
Reference: [1] Patent: US5332824, 1994, A,
  • 8
  • [ 1003-73-2 ]
  • [ 75-44-5 ]
  • [ 1603-41-4 ]
Reference: [1] Patent: US5332824, 1994, A,
  • 9
  • [ 1042146-82-6 ]
  • [ 1603-41-4 ]
  • [ 1244954-88-8 ]
Reference: [1] European Journal of Inorganic Chemistry, 2010, # 21, p. 3307 - 3316
  • 10
  • [ 74405-02-0 ]
  • [ 1603-41-4 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1980, vol. 28, # 2, p. 465 - 472
[2] Bioorganic and medicinal chemistry letters, 2000, vol. 10, # 17, p. 1975 - 1978
  • 11
  • [ 1003-73-2 ]
  • [ 1603-41-4 ]
  • [ 1603-40-3 ]
Reference: [1] Journal of Organic Chemistry, 2007, vol. 72, # 12, p. 4554 - 4557
  • 12
  • [ 104712-04-1 ]
  • [ 1603-41-4 ]
Reference: [1] Pharmaceutical Chemistry Journal, 1985, vol. 19, # 7, p. 479 - 481[2] Khimiko-Farmatsevticheskii Zhurnal, 1985, vol. 19, # 7, p. 829 - 832
  • 13
  • [ 17282-00-7 ]
  • [ 762-04-9 ]
  • [ 1603-41-4 ]
  • [ 1042146-82-6 ]
Reference: [1] Synthesis, 2008, # 10, p. 1575 - 1579
  • 14
  • [ 110-86-1 ]
  • [ 1603-41-4 ]
Reference: [1] Patent: CN107266361, 2017, A,
  • 15
  • [ 36172-53-9 ]
  • [ 1603-41-4 ]
Reference: [1] Heterocyclic Communications, 2014, vol. 20, # 1, p. 21 - 23
  • 16
  • [ 1603-41-4 ]
  • [ 2369-19-9 ]
YieldReaction ConditionsOperation in experiment
37% With tetrafluorohydroboric acid; sodium nitrite In water at -10 - 50℃; for 1 h; To a solution of 2-amino-5-methylpyridine (13) (20.0 g, 185 mmol) in fluoroboric acid (50 wtpercent in water, 50 mL), was added portionwise at -10 °C, sodium nitrite (16.6 g, 240 mmol), while maintaining the temperature below 0 °C. The reaction was stirred at 0 °C for 30 min, then at 50 °C for 30 min. After cooling to room temperature, the mixture was basified (pH 9-10) with a saturated aqueous sodium carbonate solution (250 mL) and extracted with dichloromethane (4 x 125 mL). The combined organic layers were dried over magnesium sulfate, filtered and evaporated under reduced pressure. The residue was purified by column chromatography on alumina (dichloromethane) to give 2-fluoro-5-methylpyridine (14) (7.50 g, 69 mmol) as a yellow oil. Yield 37percent; Rf (Al2O3, dichloromethane) 0.92; IR (NaCl plates) ν 1246, 1379, 1486, 2929 cm-1; 1H NMR (200 MHz, CDCl3) δ 2.25 (s, 3H, CH3), 6.75 (dd, 1H, J = 8.2 Hz, 3JH-F = 3.0 Hz, H-3), 7.52 (m, 1H, H-4), 7.94 (s, 1H, H-6); 13C NMR (50 MHz, CDCl3) δ 17.4 (CH3), 108.8 (d, 2JC-F = 38 Hz, C-3), 130.6 (C-5), 141.7 (d, 3JC-F = 8 Hz, C-4), 147.2 (d, 3JC-F = 14 Hz, C-6), 162.1 (d, 1JC-F = 236 Hz, C-2).
Reference: [1] Journal of Fluorine Chemistry, 2005, vol. 126, # 3, p. 345 - 348
[2] European Journal of Medicinal Chemistry, 2015, vol. 92, p. 818 - 838
[3] Journal of the American Chemical Society, 1949, vol. 71, p. 1125
[4] Journal of Medicinal Chemistry, 1990, vol. 33, # 6, p. 1667 - 1675
[5] Patent: US5583148, 1996, A,
[6] Journal of Labelled Compounds and Radiopharmaceuticals, 2011, vol. 54, # 6, p. 312 - 317
  • 17
  • [ 1603-41-4 ]
  • [ 3510-66-5 ]
YieldReaction ConditionsOperation in experiment
90%
Stage #1: With hydrogen bromide; bromine In water at -20℃; for 3 h;
Stage #2: at -20℃; for 1 h;
Procedure B Intermediate 7: 2- [[6-MORPHOLIN-4-YL-PYRIDIN-3-YL] ETHANAMINE] Step 1: 2-Bromopicoline To a stirred solution of 2-amino-5-picoline (120g, 1. [10MOL)] in 1. 5L of 48percent HBr was added [160ML] [OF BR2] (498g, 3. [1MOL) AT-20°C] over a period of lh and then allowed to stir at same temperature for 2h. To this mixture was added slowly a solution [OF NAN02] (204g, 2. [95MOL,] in 300mL of water) and the resuting solution was allowed to stir for another lh [AT-20°C.] The reaction mixture was quenched at-20°C by addition of aqueous [NAOH] [(1.] 2Kg of [NAOH] in 2L of water) then extracted with diethyl ether [(3XLL).] The organic layer was washed with water, brine, dried with [NA2SO4] and concentrated to give a crude residue. After purification by distillation (bath temp. [130°C,] vacuum temp. [85-90°C,] vacuum=0. [01MM),] 172g 2-bromopicoline were obtained as off white low melting solid (90percent). [TLC, Rf= 0.8, diethyl ether]
94% With sodium hydroxide; hydrogen bromide; sodium nitrite In water Step 3:
Preparation of 2-bromo-5-picoline.
A solution of 1500 mL (14 mol) of 48percent hydrobromic acid was cooled to 10° C. and 300 g (2.8 mol) of 2-amino-5-picoline (Aldrich) was added slowly.
The solution was maintained at or below 0° C. while 450 mL (8.8 mol) of bromime was added dropwise.
After the bromine addition was complete, a solution of 500 g (7.3 mol) of sodium nitrite in 1000 mL of water was added slowly over 6 h.
The reaction pH was adjusted by the careful addition of 1500 mL (56 mol) of 50percent sodium hydroxide at such a rate that the temperature was maintained below 30° C.
The product precipitated from the nearly colorless reaction mixture; filtration gave 450 g (94percent) of 2-bromo-5-picoline as a yellow powder: mp 38°-40° C.; NMR 7.27 (s, 1H), 7.28 (s, 1H), 7.12 (br s, 1H).
94% With sodium hydroxide; hydrogen bromide; bromine; sodium nitrite In water Step 3:
Preparation of 2-bromo-5-picoline
A solution of 1500 mL (14 mol) of 48percent hydrobromic acid was cooled to 10° C. and 300 g (2.8 mol) of 2-amino-5-picoline (Aldrich) was added slowly.
The solution was maintained at or below 0° C. while 450 mL (8.8 mol) of bromine was added dropwise.
After the bromine addition was complete, a solution of 500 g (7.3 mol) of sodium nitrite in 1000 mL of water was added slowly over 6 h.
The reaction pH was adjusted by the careful addition of 1500 mL (56 mol) of 50percent sodium hydroxide at such a rate that the temperature was maintained below 30° C.
The product precipitated from the nearly colorless reaction mixture; filtration gave 450 g (94percent) of 2-bromo-5-picoline as a yellow powder: mp 38-40° C.; NMR 7.27 (s, 1H), 7.28 (s, 1H), 7.12 (br s, 1H).
94% With sodium hydroxide; hydrogen bromide; bromine; sodium nitrite In water Step 3:
Preparation of 2-bromo-5-picoline.
A solution of 1500 mL (14 mol) of 48percent hydrobromic acid was cooled to 10° C. and 300 g (2.8 mol) of 2-amino-5-picoline (Aldrich) was added slowly.
The solution was maintained at or below 0° C. while 450 mL (8.8 mol) of bromine was added dropwise.
After the bromine addition was complete, a solution of 500 g (7.3 mol) of sodium nitrite in 1000 mL of water was added slowly over 6 h.
The reaction pH was adjusted by the careful addition of 1500 mL (56 mol) of 50percent sodium hydroxide at such a rate that the temperature was maintained below 30° C.
The product precipitated from the nearly colorless reaction mixture; filtration gave 450 g (94percent) of 2-bromo-5-picoline as a yellow powder: mp 38°-40° C.; NMR 7.27 (s, 1 H), 7.28 (s, 1 H), 7.12 (br s, 1 H).
94% With sodium hydroxide; hydrogen bromide; bromine; sodium nitrite In water Step 3:
Preparation of 2-bromo-5-picoline
A solution of 1500 mL (14 mol) of 48percent hydrobromic acid was cooled to 10° C. and 300 g (2.8 mol) of 2-amino-5-picoline (Aldrich) was added slowly.
The solution was maintained at or below 0° C. while 450 mL (8.8 mol) of bromine was added dropwise.
After the bromine addition was complete, a solution of 500. g (7.3 mol) of sodium nitrite in 1000 mL of water was added slowly over 6 h.
The reaction pH was adjusted by the careful addition of 1500 mL (56 mol) of 50percent sodium hydroxide at such a rate that the temperature was maintained below 30° C.
The product precipitated from the nearly colorless reaction mixture; filtration gave 450 g (94percent) of 2-bromo-5-picoline as a yellow powder: mp 38°-40° C.; NMR 7.27 (s, 1H), 7.28 (s, 1H), 7.12 (br s, 1H).

Reference: [1] Synthesis, 1994, # 1, p. 87 - 92
[2] Phosphorus, Sulfur and Silicon and the Related Elements, 2002, vol. 177, # 11, p. 2579 - 2587
[3] Patent: WO2003/106455, 2003, A1, . Location in patent: Page 55
[4] Organic Letters, 2000, vol. 2, # 21, p. 3373 - 3376
[5] Tetrahedron Letters, 1998, vol. 39, # 47, p. 8643 - 8644
[6] Chemistry - A European Journal, 2018, vol. 24, # 55, p. 14622 - 14626
[7] Chemistry - A European Journal, 2018, vol. 24, # 50, p. 13158 - 13169
[8] Journal of the American Chemical Society, 1946, vol. 68, p. 2574,2576
[9] Journal of the American Chemical Society, 1950, vol. 72, p. 4362
[10] Journal of Organic Chemistry, 1953, vol. 18, p. 598,604
[11] Journal of Organic Chemistry, 1949, vol. 14, p. 509,513
[12] Organic Magnetic Resonance, 1982, vol. 20, # 4, p. 242 - 248
[13] Synthesis, 1999, # 5, p. 779 - 782
[14] Tetrahedron Letters, 2001, vol. 42, # 35, p. 6113 - 6115
[15] Tetrahedron Letters, 2005, vol. 46, # 36, p. 6033 - 6036
[16] Tetrahedron Letters, 2006, vol. 47, # 20, p. 3471 - 3473
[17] Patent: US5861420, 1999, A,
[18] Patent: US6090828, 2000, A,
[19] Patent: US5196537, 1993, A,
[20] Patent: US5451593, 1995, A,
[21] Patent: US4184041, 1980, A,
[22] Patent: US6214878, 2001, B1,
  • 18
  • [ 1603-41-4 ]
  • [ 3510-66-5 ]
YieldReaction ConditionsOperation in experiment
75% With sodium hydroxide; bromine; sodium nitrite In water; hydrogen bromide EXAMPLE 28
3-(4-[5-Methyl-2-pyridyl]piperazin-1-yl)methyl-1H-pyrrolo[2,3-b]pyridine
Bromine (74 g, 24 ml, 0.46 mmol) was added dropwise with vigorous stirring to a solution of 2-amino-5-picoline (20.0 g, 0.19 mol) in 48percent hydrobromic acid (300 ml) at -10° C. Sodium nitrite (32 g, 0.46mol) in water (80 ml) was added dropwise to the orange suspension, maintaining the temperature below -5° C., and the mixture was then stirred at room temperature for 30 minutes.
The mixture was recooled to 0° C. and sodium hydroxide (188 g, 4.7 mol) in water (160 ml) added dropwise.
The resulting black suspension was extracted with ether (2*500 ml), the extracts combined, dried (MgSO4), and evaporated to give 2-bromo-5-picoline as a tan solid (24 g, 75percent); δH (CDCl3) 2.30 (3H, s, CH3), 7.38 (2H, s, 3-H, 4-H)
8.21 (1H, s, 6-H).
This was converted in two steps, using the procedure outlined in Example 10, to the title compound, m.p. 204°-205° C. (EtOAc); (Found: C, 70.53; H, 6.86; N, 22.86. C18 H21 N5 requires C, 70.33; H, 6.89; N, 22.78percent); δH (DMSO-d6) 2.12 (3H, s, ArCH3), 2.47 (4H, m, 2*piperazinyl CH2), 3.39 (4H, m, 2*piperazinyl CH2), 3.66 (2H, s, CH2 N), 6.70 (1H, d, J 8.6 Hz, 3'-H), 7.04 (1H, dd, J 7.8, 4.7 Hz, 5-H), 7.34 (1H, dd, J 8.6, 2.3 Hz, 4'-H), 7.36 (1H, d, J 2.3 Hz, 2-H), 7.92 (1H, d, J 2.3
Hz, 6'-H), 8.05 (1H, dd, J 7.8, 1.2 Hz, 4-H), 8.19 (1H, dd, J 4.7, 1.5 Hz, 6-H), and 11.45 (1H, br s, NH); m/z (CI+, NH3) 308 (M+1)+.
Reference: [1] Patent: US5432177, 1995, A,
  • 19
  • [ 1603-41-4 ]
  • [ 3510-66-5 ]
Reference: [1] Patent: US4574125, 1986, A,
  • 20
  • [ 108-99-6 ]
  • [ 1603-41-4 ]
  • [ 1603-40-3 ]
YieldReaction ConditionsOperation in experiment
1928 g With ammonia; sodium; ethanolamine In toluene at 60 - 170℃; Autoclave; Inert atmosphere; Large scale 1) Add 9021g of toluene, 538g of sodium metal, 70g of ethanolamine and 1900g of 3-picoline to the autoclave. After tightening the autoclave, open the autoclave inlet and the addition port of the dropping tank, and open the dropping tank And the kettle body valve, the hose through the feeding port into the bottom of the tank, with nitrogen replacement air for 1min, closed the lid of the feeding port, warmed to 60 , dropping liquid ammonia, control the pressure in the autoclave 3MPa, the final Liquid ammonia added amount of 600g. Fully respond.2) The temperature was raised to 170 ° C, nitrogen was filled to a pressure of 5 MPa, and the reaction was sufficiently completed. When the pressure in the autoclave increased to 5.5 MPa,Pressure relief to 5MPa, repeat this operation until the pressure inside the reactor does not rise as the end of the reaction, down to room temperature.3) The ammoniated liquid was taken out and slowly added dropwise to water (9 kg). The mixture was stirred and hydrolyzed and extracted, and the mixture was allowed to stand still. After the aqueous phase was extracted again with 3 L of toluene, the oil phases were combined and the oil phase was quantified by gas chromatography.Among them, 1928g of 2-amino-5-methylpyridine and 144g of 2-amino-3-methylpyridine.
Reference: [1] Patent: US2456379, 1946, ,
[2] Patent: CN106496105, 2017, A, . Location in patent: Paragraph 0024; 0025; 0026; 0027; 0028; 0029; 0030-0035
  • 21
  • [ 1003-73-2 ]
  • [ 1603-41-4 ]
  • [ 1603-40-3 ]
Reference: [1] Journal of Organic Chemistry, 2007, vol. 72, # 12, p. 4554 - 4557
  • 22
  • [ 1603-41-4 ]
  • [ 24638-29-7 ]
Reference: [1] Journal of Medicinal Chemistry, 1997, vol. 40, # 22, p. 3679 - 3686
[2] Journal of the American Chemical Society, 1950, vol. 72, p. 2806
[3] Patent: US5620978, 1997, A,
  • 23
  • [ 1603-41-4 ]
  • [ 1074-38-0 ]
Reference: [1] Journal of the American Chemical Society, 2017, vol. 139, # 13, p. 4611 - 4614
[2] Advanced Synthesis and Catalysis, 1997, vol. 339, # 4, p. 335 - 339
[3] Journal of the American Chemical Society, 1951, vol. 73, p. 494
[4] Organic Letters, 2012, vol. 14, # 21, p. 5618 - 5620
  • 24
  • [ 1603-41-4 ]
  • [ 403-45-2 ]
Reference: [1] Journal of Medicinal Chemistry, 1990, vol. 33, # 6, p. 1667 - 1675
[2] Journal of the American Chemical Society, 1949, vol. 71, p. 1125
[3] Journal of Labelled Compounds and Radiopharmaceuticals, 2011, vol. 54, # 6, p. 312 - 317
  • 25
  • [ 1603-41-4 ]
  • [ 6311-35-9 ]
Reference: [1] Synthesis, 1994, # 1, p. 87 - 92
[2] Journal of Organic Chemistry, 1949, vol. 14, p. 509,513
  • 26
  • [ 1603-41-4 ]
  • [ 329-89-5 ]
Reference: [1] Bollettino Chimico Farmaceutico, 1957, vol. 96, p. 542,543
  • 27
  • [ 1603-41-4 ]
  • [ 6271-78-9 ]
Reference: [1] Journal of Organic Chemistry, 1949, vol. 14, p. 509,513
  • 28
  • [ 1603-41-4 ]
  • [ 36052-24-1 ]
Reference: [1] Bollettino Chimico Farmaceutico, 1957, vol. 96, p. 542,543
  • 29
  • [ 1603-41-4 ]
  • [ 26218-78-0 ]
Reference: [1] Journal of Organic Chemistry, 1949, vol. 14, p. 509,513
  • 30
  • [ 1603-41-4 ]
  • [ 67-56-1 ]
  • [ 26218-78-0 ]
Reference: [1] Patent: US6335343, 2002, B1, . Location in patent: Page column 48
  • 31
  • [ 1603-41-4 ]
  • [ 23056-40-8 ]
Reference: [1] Patent: EP2366691, 2011, A1,
[2] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 5, p. 985 - 995
  • 32
  • [ 1603-41-4 ]
  • [ 7464-14-4 ]
YieldReaction ConditionsOperation in experiment
61.9%
Stage #1: at 0 - 5℃; for 2 h;
Stage #2: for 4 h; Cooling with ice
Example 3: Synthesis of 2-(1-ethyleneimine)-5-carbamoyl-3-nitropyridine (compound III) [Show Image] The reagents used is ( i ) HNO3/H2SO4, followed by NaNO2; (ii) POCl3; (iii) Na2Cr2O7; (iv) SOCl2, followed by NH4OH/THF; (v) aziridine.Synthesis of the compound 14 A concentrated sulphuric acid (25 mL) was cooled in an ice bath, the starting material compound 13 (5 g, 0.0462 mol) was slowly added and cooled to 0°C, 6 mL of a mixture in volumetric ratio of 1:1 of a concentrated sulphuric acid (98percent) and a concentrated nitric acid (72percent) was slowly added, and the reaction proceeded at 0-5°C for 2 h. The reaction liquid was introduced into 100 mL of ice-water, supplemented further with 6g sodium nitrite, and stirred in an ice-bath for additional 4h. A solid was precipitated and filtered. The filter cake was dried to obtain 4.4g of the compound 14. The yield was 61.9percent. The melting point is 177-178 °C (water) (M.P. 178-180 °C was reported in the reference) [J.O.C. , 1944, 14, 328-332].
24%
Stage #1: at 0℃; for 2 h;
Stage #2: at 0℃; for 4 h;
A solution of 2-amino-5-picoline (5 g, 46 mmol) in c-H2SO4 (25 mL) was cooled in an ice bath.
A mixture of c-H2SO4 (3 mL) and c-HNO3 (3 mL) was added slowly with stirring.
This mixture was then stirred at 0 °C for 2 h.
The mixture was poured into 100 mL of ice water and then NaNO2 (6 g) was added.
The resulting mixture was stirred for 4 h at 0 °C.
The precipitate solid obtained was filtered off, washed with water, and dried to give product 3 as an orange solid (1.7 g, 24percent).
1H NMR (300 MHz, DMSO-d6) δ: 12.69 (s, 1H), 8.35 (d, J = 2.7 Hz, 1H), 7.73 (d, J = 2.4 Hz, 1H), 2.10 (s, 3H).
Reference: [1] Patent: EP2366691, 2011, A1, . Location in patent: Page/Page column 8-9
[2] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 5, p. 985 - 995
[3] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 23, p. 9948 - 9956
  • 33
  • [ 1603-41-4 ]
  • [ 7598-26-7 ]
YieldReaction ConditionsOperation in experiment
27%
Stage #1: at -10 - 20℃; for 1 h;
Stage #2: With nitric acid In water at 55 - 60℃; for 0.5 h;
Stage #3: With sodium hydroxide In water at 0℃;
Example 170: 5-methyl-3-nitro-pyridin-2-ylamine; [00577] Sulfuric acid (97percent, 100 mL) was placed in a -10 °C bath and when the internal temperature reached to 5 °C, 2-amino-picoline (25 g, 231.2 mmol) was added in small portions with stirring (in1 h). The suspension was stirred at ambient temperature to dissolve rest of the solid. The resulting solution was heated to 55 °C and 70percent cone. HNO3 (15.6 mL) was added dropwise while maintaining the internal temperature between 55-60 °C. The mixture was stirred further 30 min after the addition, poured into crushed ice (800 g), stirred to get solution and treated with 40percent aqueous NaOH solution at 0 °C to reach pH 9 and extracted with CHCb (3 x 250 mL). Combined organic layers were washed with brine (2 x 200 mL), dried (anhydrous Na2SO4) and concentrated under reduced pressure to afford 5-methyl-3-nitro-pyridin-2-ylamine (9.49 g) as yellow solid in 27percent yield. ESMS m/z (relative intensity): 154 (M+H)+ (100).
Reference: [1] Patent: WO2006/76644, 2006, A2, . Location in patent: Page/Page column 204
[2] Journal of Medicinal Chemistry, 1997, vol. 40, # 22, p. 3679 - 3686
[3] Journal of the American Chemical Society, 1951, vol. 73, p. 3504
[4] Journal of the American Chemical Society, 1950, vol. 72, p. 2806
[5] Journal of the American Chemical Society, 1955, vol. 77, p. 3154
  • 34
  • [ 1603-41-4 ]
  • [ 7598-26-7 ]
Reference: [1] Patent: US5620978, 1997, A,
  • 35
  • [ 1603-41-4 ]
  • [ 7477-10-3 ]
Reference: [1] Patent: EP2366691, 2011, A1,
[2] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 5, p. 985 - 995
  • 36
  • [ 1603-41-4 ]
  • [ 1802-30-8 ]
Reference: [1] Journal of the American Chemical Society, 1946, vol. 68, p. 2574,2576
  • 37
  • [ 1603-41-4 ]
  • [ 59782-87-5 ]
Reference: [1] European Journal of Medicinal Chemistry, 2015, vol. 92, p. 818 - 838
  • 38
  • [ 1603-41-4 ]
  • [ 17282-00-7 ]
YieldReaction ConditionsOperation in experiment
90% at 20℃; Bromine (11.3 mL, 0.22 mol) was added to a stirred solution of 2-amino-5-picoline (21.63 g, 0.2 mol) and sodium acetate (29.4 g, 0.36 mol) in acetic acid (200 mL) at room temperature. The warm solution was stirred until starting material had been consumed as judged by alumina neutral thin layer chromatography (CH2Cl2). The dark brown solution was diluted with H2O (100 mL) and decolourised with sodium sulphite. The colourless solution was cooled with an ice bath and carefully basified to ~pH 9 with aqueous ammonia. The copious white precipitate was collected by filtration and washed well with portions of H2O (3 x 30 mL). The precipitate was dried in an oven at 110 °C to give 4 (33.7 g, 90percent) as a fluffy white solid. 1H NMR δ (400 MHz, CDCl3) 7.77 (1 H, d, J 1.0, H-6), 7.52 (1 H, d, J 1.5, H-4), 5.21 (2 H, s, NH2), 2.18 (3 H, s, CH3). LCMS (APCI+) 187.9 (MH+ with 79Br, 95percent), 189.9 (MH+ with 81Br, 100percent).
84% With bromine In dichloromethane at 20℃; for 0.5 h; Cooling with ice A three-necked flask was charged with 2-amino-5-methylpyridine (70.0 g, 654 mmol) Dichloromethane (150 mL);Liquid bromine (36.0 mL, 698 mmol) was added to the ice bath. The reaction was stirred at room temperature for 30 minutes. Saturated sodium sulfite solution (100 mL) was added;The aqueous phase was extracted with dichloromethane (100 mL x 3)The organic phases were combined, washed with water (100 mL) and brine (100 mL)Dry over sodium sulfate and filter. Dried to give a yellow solid,Compound 1 (103.0 g, 550 mmol, 84percent).
53%
Stage #1: With hydrogen bromide; acetic acid In chloroform at 50℃; for 0.5 h; Darkness
Stage #2: With bromine In chloroform at 55℃; for 21 h;
Stage #3: With sodium carbonate In chloroform; water
General procedure: A solution of HBr/CH3CO2H (360 g (260 mL), 1.50 mol, 33percent HBr in CH3CO2H) in anhydrous CHCl3 (300 mL) was added over 15 min to a solution of 5-methylpyrazin-2-amine 15 (42 g, 0.38 mmol) in CHCl3 (1 L). The reaction flask was wrapped in aluminum foil and heated to 50 °C for 30 min in the dark whereupon a solution of Br2 (68 g, 0.42 mmol) in CHCl3 (500 mL) was added dropwise over 3 h during which time the internal temperature of the reaction never exceeded 55 °C. After 18 h at 55 °C the solvent was evaporated under reduced pressure. The crude mixture was diluted with water (200 mL) and the pH was adjusted to pH=9 by the addition of solid Na2CO3. The suspension was filtered under vacuum and the filtrate was extracted with EtOAc (1 L.x.5). The combined organic extracts were concentrated under reduced pressure and purified by flash silica gel chromatography eluting with petroleum ether/EtOAc (5:1-->1:1) to give compound 6-bromo-5-methylpyrazin-2-amine 17a (36 g, 50percent) as a light orange solid
Reference: [1] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 13, p. 3796 - 3808
[2] Patent: CN107056781, 2017, A, . Location in patent: Paragraph 0008
[3] Journal fuer Praktische Chemie (Leipzig), 1989, vol. 331, # 3, p. 369 - 374
[4] Journal fuer Praktische Chemie (Leipzig), 1989, vol. 331, # 3, p. 369 - 374
[5] Tetrahedron, 2011, vol. 67, # 47, p. 9063 - 9066
[6] Heterocycles, 1994, vol. 38, # 3, p. 529 - 540
[7] Tetrahedron Letters, 1995, vol. 36, # 30, p. 5319 - 5322
[8] Bioorganic and Medicinal Chemistry Letters, 1998, vol. 8, # 19, p. 2777 - 2782
[9] Patent: US5861419, 1999, A,
[10] Patent: US4246419, 1981, A,
[11] Patent: US4302242, 1981, A,
[12] Patent: US4317913, 1982, A,
[13] Patent: WO2006/25783, 2006, A1, . Location in patent: Page/Page column 143-144
[14] Dyes and Pigments, 2012, vol. 92, # 3, p. 1184 - 1191
  • 39
  • [ 1603-41-4 ]
  • [ 824-52-2 ]
Reference: [1] Patent: CN107056781, 2017, A,
  • 40
  • [ 1603-41-4 ]
  • [ 23100-12-1 ]
Reference: [1] Synthesis, 1994, # 1, p. 87 - 92
  • 41
  • [ 1603-41-4 ]
  • [ 127-19-5 ]
  • [ 5308-63-4 ]
Reference: [1] Tetrahedron Letters, 1995, vol. 36, # 15, p. 2551 - 2554
  • 42
  • [ 1603-41-4 ]
  • [ 21543-49-7 ]
Reference: [1] Synthesis, 1994, # 1, p. 87 - 92
  • 43
  • [ 1603-41-4 ]
  • [ 70258-18-3 ]
Reference: [1] Patent: CN105801472, 2016, A,
  • 44
  • [ 1603-41-4 ]
  • [ 101990-45-8 ]
Reference: [1] Synthesis, 1994, # 1, p. 87 - 92
  • 45
  • [ 1603-41-4 ]
  • [ 53515-23-4 ]
  • [ 189005-44-5 ]
YieldReaction ConditionsOperation in experiment
82% With sodium carbonate In water at 60℃; for 6 h; Inert atmosphere Water (100 mL), 3-bromo-4- (4-methylphenyl) -4- oxobutanoic acid (25.12 g, 0.093 mol)2-Amino-5-methylpyridine (3) (10.02 g, 0.093 mol)And sodium carbonate (9.86 g, 0.093 mol) were successively added to a 500 mL reaction flask, After mixing,Slowly warmed to an internal temperature of 60 ° C,Nitrogen protection, thermal reaction 6h,Stop the reaction.With 6N hydrochloric acid pH = 0.5 ~ 1,Stirred at room temperature for 30min,No change in pH after the test, adding an equal amount of ethyl acetate,Stir 15min, points to the reservoir,Water layer plus activated carbon 0.5g, 50 decolorization 30min, hot filtration,The filtrate was adjusted with 6N aqueous sodium hydroxide pH = 3.0 ~ 3.5,Precipitation solid, cooled to 0 ~ 5 insulation 1h, suction filtration,The filter cake was rinsed with 50 mL of ice water and dried under vacuum at 80 ° C. for 6 h.21.38 g (HPLC: 99.2percent) of a light yellow solid was obtained in a yield of 82.0percent.
Reference: [1] Patent: CN107383005, 2017, A, . Location in patent: Paragraph 0054; 0055-0063; 0070; 0071; 0072-0079
  • 46
  • [ 1603-41-4 ]
  • [ 68261-97-2 ]
  • [ 189005-44-5 ]
YieldReaction ConditionsOperation in experiment
52% With sodium carbonate In water at 80℃; for 7 h; Inert atmosphere Water (20 mL),3-Chloro-4- (4-methylphenyl) -4-oxobutanoic acid(5.02 g, 0.022 mol),2-Amino-5-methylpyridine (3) (3.58 g, 0.033 mol)And sodium carbonate (2.33 g, 0.022 mol) were successively added to a 100 mL reaction flask,After mixing,Slowly warmed to 80 internal temperature, nitrogen protection,Insulation reaction 7h, stop the reaction.With 6N hydrochloric acid pH = 0.5 ~ 1, Stirred at room temperature for 30min,No change in pH after the test, adding an equal amount of ethyl acetate,Stir 15min, points to the reservoir,Water layer plus activated carbon 0.1g, 50 decolorization 30min, hot filtration,The filtrate was adjusted to pH = 3.0 ~ 3.5 with 6N aqueous sodium hydroxide solution to precipitate a solid,Cooling to 0 ~ 5 insulation 1h, suction filtration, the filter cake with 10mL ice water rinse,80 vacuum drying 6h,3.21 g of pale yellow solid (HPLC: 97.6percent) was obtained in a yield of 52.0percent.
Reference: [1] Patent: CN107383005, 2017, A, . Location in patent: Paragraph 0064; 0065; 0066; 0067; 0068; 0069
  • 47
  • [ 1603-41-4 ]
  • [ 189005-44-5 ]
Reference: [1] Organic Letters, 2012, vol. 14, # 17, p. 4580 - 4583
[2] Organic Letters, 2017, vol. 19, # 9, p. 2226 - 2229
[3] Journal of Pharmacy and Pharmacology, 2018, vol. 70, # 9, p. 1164 - 1173
  • 48
  • [ 1603-41-4 ]
  • [ 149806-06-4 ]
Reference: [1] Tetrahedron Letters, 2005, vol. 46, # 36, p. 6033 - 6036
[2] Synthesis, 1994, # 1, p. 87 - 92
[3] Synthesis, 1994, # 1, p. 87 - 92
  • 49
  • [ 1603-41-4 ]
  • [ 153034-78-7 ]
Reference: [1] European Journal of Medicinal Chemistry, 2015, vol. 92, p. 818 - 838
  • 50
  • [ 1603-41-4 ]
  • [ 205744-17-8 ]
Reference: [1] Journal of Fluorine Chemistry, 2005, vol. 126, # 3, p. 345 - 348
  • 51
  • [ 1603-41-4 ]
  • [ 663619-89-4 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 13, p. 3796 - 3808
  • 52
  • [ 1603-41-4 ]
  • [ 448968-52-3 ]
Reference: [1] Journal of the American Chemical Society, 2017, vol. 139, # 13, p. 4611 - 4614
  • 53
  • [ 1603-41-4 ]
  • [ 202348-55-8 ]
Reference: [1] European Journal of Organic Chemistry, 2015, vol. 2015, # 18, p. 3957 - 3962
  • 54
  • [ 1603-41-4 ]
  • [ 442129-37-5 ]
Reference: [1] Patent: WO2008/141119, 2008, A2,
  • 55
  • [ 1603-41-4 ]
  • [ 586409-05-4 ]
Reference: [1] Dyes and Pigments, 2012, vol. 92, # 3, p. 1184 - 1191
  • 56
  • [ 1603-41-4 ]
  • [ 1023814-35-8 ]
Reference: [1] Organic Letters, 2013, vol. 15, # 13, p. 3460 - 3463
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1603-41-4 ]

Amines

Chemical Structure| 1603-40-3

[ 1603-40-3 ]

3-Methylpyridin-2-amine

Similarity: 0.84

Chemical Structure| 113293-71-3

[ 113293-71-3 ]

(6-Aminopyridin-3-yl)methanol

Similarity: 0.83

Chemical Structure| 461-88-1

[ 461-88-1 ]

Pyridine-2,4-diamine

Similarity: 0.77

Chemical Structure| 27225-00-9

[ 27225-00-9 ]

2,7-Naphthyridin-1-amine

Similarity: 0.73

Chemical Structure| 51566-22-4

[ 51566-22-4 ]

3-Methylpyridine-2,6-diamine

Similarity: 0.73

Related Parent Nucleus of
[ 1603-41-4 ]

Pyridines

Chemical Structure| 1603-40-3

[ 1603-40-3 ]

3-Methylpyridin-2-amine

Similarity: 0.84

Chemical Structure| 113293-71-3

[ 113293-71-3 ]

(6-Aminopyridin-3-yl)methanol

Similarity: 0.83

Chemical Structure| 461-88-1

[ 461-88-1 ]

Pyridine-2,4-diamine

Similarity: 0.77

Chemical Structure| 51566-22-4

[ 51566-22-4 ]

3-Methylpyridine-2,6-diamine

Similarity: 0.73

Chemical Structure| 42182-27-4

[ 42182-27-4 ]

2-Amino-4-cyanopyridine

Similarity: 0.72